Keystone Financial Group Pfizer Inc Transaction History

Keystone Financial Group

$274 Million
Q2 2024

A detailed history of Keystone Financial Group transactions in Pfizer Inc stock. As of the latest transaction made, Keystone Financial Group holds 60,572 shares of PFE stock, worth $1.7 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

60,572

Previous 52,124 16.21%

Holding current value

$1.7 Million

Previous $1.45 Million 17.15%

% of portfolio

0.62%

Previous 0.21%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$25.26 - $29.6 $213,396 - $250,060	8,448 Added 16.21%	60,572 $1.69 Million
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $368,026 - $422,611	14,215 Added 37.5%	52,124 $1.45 Million
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $92,474 - $120,113	3,539 Added 10.3%	37,909 $1.09 Million
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $68,576 - $80,158	2,137 Added 6.63%	34,370 $1.14 Million
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $146,286 - $169,249	4,050 Added 14.37%	32,233 $1.18 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $4,634 - $6,049	-111 Reduced 0.39%	28,183 $1.44 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $45,510 - $55,556	1,040 Added 3.82%	28,294 $1.24 Million
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $791 - $937	-17 Reduced 0.06%	27,254 $1.43 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $76,539 - $94,842	1,673 Added 6.54%	27,271 $1.41 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $164,288 - $243,530	3,976 Added 18.39%	25,598 $1.51 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $15,307 - $19,663	390 Added 1.84%	21,622 $930,000
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $7,253 - $8,217	202 Added 0.96%	21,232 $831,000
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $44,541 - $50,234	1,330 Added 6.75%	21,030 $762,000
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $36,147 - $45,964	1,080 Added 5.8%	19,700 $725,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $33,337 - $39,112	1,050 Added 5.98%	18,620 $683,000
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $3,042 - $3,690	101 Added 0.58%	17,570 $575,000
Q1 2020 May 05, 2020	BUY	$27.03 - $38.62 $55,114 - $78,746	2,039 Added 13.21%	17,469 $570,000
Q4 2019 Feb 06, 2020	BUY	$32.92 - $37.36 $12,641 - $14,346	384 Added 2.55%	15,430 $605,000
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $15,790 - $20,475	-486 Reduced 3.13%	15,046 $541,000
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $10,280 - $11,542	278 Added 1.82%	15,532 $673,000
Q1 2019 May 07, 2019	BUY	$37.5 - $41.2 $30,075 - $33,042	802 Added 5.55%	15,254 $648,000
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $12,502 - $14,254	-325 Reduced 2.2%	14,452 $631,000
Q3 2018 Nov 06, 2018	BUY	$34.47 - $41.81 $141,775 - $171,964	4,113 Added 38.57%	14,777 $654,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $9,498 - $10,126	-288 Reduced 2.63%	10,664 $387,000
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $14,997 - $17,399	470 Added 4.48%	10,952 $384,000
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $348,631 - $369,909	10,482	10,482 $382,000

Others Institutions Holding PFE

# of Institutions

3,240

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $158B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Financial Group with notifications on news.

Account

Keystone Financial Group Pfizer Inc Transaction History